INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Other Accrued Liabilities
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Other Accrued Liabilities of $0 for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2021-08-09
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2021-06-30 was -$35.37K, a 2283.33% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2021-03-31 was $35.37K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2020-09-30 was $197.14K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2020-06-30 was $1.62K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 9 month as first filed |
|---|---|---|---|---|---|
| 2021-06-30 | -$35.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $35.37K 10-Q · filed 2021-05-10 | ||||
| 2020-09-30 | $197.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $198.76K derived: sum of 2 quarters · filed 2021-08-09 | $198.76K 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | $1.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.62K 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$68.81K derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$68.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $68.81K 10-Q · filed 2020-05-11 | ||||
| 2018-09-30 | $159.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $23.96K derived: sum of 2 quarters · filed 2019-11-12 | $188.25K 10-Q · filed 2019-11-12 | $1.07M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$135.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $29.21K 10-Q · filed 2019-08-08 | $1.22M 10-Q · filed 2018-08-07 | ||
| 2018-03-31 | $164.29K 10-Q · filed 2019-05-09 | ||||
| 2017-09-30 | $624.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.30M derived: sum of 2 quarters · filed 2018-11-08 | $1.81M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $674.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.19M 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | $511.05K 10-Q · filed 2018-05-09 | ||||
| 2016-09-30 | $280.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $169.98K 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | -$110.14K 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |